| Jan 9, 2025 |
Jan 13, 2025 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
91.3
|
+17,122
|
27.32%
|
✗
|
$29.9K |
| Oct 1, 2024 |
Oct 2, 2024 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
91.3
|
+8,637
|
15.98%
|
✗
|
$18.6K |
| Jan 9, 2024 |
Jan 11, 2024 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
91.3
|
+21,120
|
64.17%
|
✗
|
$18.1K |
| Sep 1, 2023 |
Sep 5, 2023 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
27.5
|
-2,908
|
-8.12%
|
✗
|
$6.3K |
| Jan 9, 2023 |
Jan 11, 2023 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
90.0
|
+15,341
|
74.90%
|
✗
|
$8.1K |
| Sep 1, 2022 |
Sep 2, 2022 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
26.3
|
-11,959
|
-3.75%
|
✗
|
$35K |
| Jan 10, 2022 |
Jan 12, 2022 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
90.0
|
+56,806
|
21.65%
|
✗
|
$7.1K |
| Sep 1, 2021 |
Sep 3, 2021 |
LISATA THERAPEUTICS, INC.
|
EVP, R&D and CMO |
Sell |
95.0
|
+262,397
|
100.00%
|
✗
|
$64.1K |